Publications

Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.
Am J Pathol 2017 May 9;187(5):980-986. Epub 2017 Mar 9.
Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Leuk Lymphoma 2017 Jan 9;58(1):53-63. Epub 2016 May 9.
a Department of Pathology , Seoul National University Hospital, Seoul National University College of Medicine , Seoul , South Korea.

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
Histopathology 2016 Jun 1;68(7):1079-89. Epub 2015 Dec 1.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.

Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Mol Cancer Ther 2016 Jun 16;15(6):1387-96. Epub 2016 Feb 16.
Tumor Immunity Medical Research Center, Cancer Research Center, Seoul National University College of Medicine, Seoul, South Korea. Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, South Korea. Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.

EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3.
Oncoimmunology 2016 Mar 29;5(3):e1108514. Epub 2015 Oct 29.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Ischemic/Hypoxia Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.



Sound packing DNA: packing open circular DNA with low-intensity ultrasound.
Sci Rep 2015 Apr 20;5:9846. Epub 2015 Apr 20.
Department of Pathology, Tumor Immunity Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL).
Ann Hematol 2015 Mar 11;94(3):437-44. Epub 2014 Oct 11.
Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, South Korea.

Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.
BMC Cancer 2014 Dec 3;14:911. Epub 2014 Dec 3.
Tumor Immunity Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.
Leuk Lymphoma 2014 Nov 3;55(11):2466-76. Epub 2014 Mar 3.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine , Seoul , Korea.


Twenty-four-week multicenter, evaluator-blinded clinical study of the efficacy and safety of a dextran filler in the treatment of nasolabial folds.
Dermatol Surg 2014 Jun;40(6):652-7
*Department of Dermatology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea; †Department of Dermatology, Kangwon National University Hospital, Kangwon University College of Medicine, Chuncheon, Korea; ‡Department of Dermatology, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Uijeongbu, Korea.

Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
Exp Mol Med 2014 Apr 11;46:e90. Epub 2014 Apr 11.
1] Department of Pathology, Seoul National University College of Medicine, Seoul, Korea [2] The Tumor Immunity Medical Research Center, Cancer Research Center, Seoul National University College of Medicine, Seoul, Korea.


Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma.
Cancer 2013 Mar 4;119(6):1195-202. Epub 2012 Dec 4.
Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.


The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
Mol Cancer 2011 Aug 16;10:98. Epub 2011 Aug 16.
Department of Pathology, Cancer Research Institute, Seoul National University College of Medicine, 28 Yeongeon-dong, Jongno-gu, Seoul 110-799, South Korea.

CpG Oligodeoxynucleotides Enhance the Activities of CD8+ Cytotoxic T-Lymphocytes Generated by Combined hMUC1 Vaccination and hNIS Radioiodine Gene Therapy.
Nucl Med Mol Imaging 2010 Sep 13;44(3):199-206. Epub 2010 Jul 13.
Department of Nuclear Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul, 110-744 Korea ; Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul, Korea ; Laboratory of Molecular Imaging and Therapy of Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
Mol Cancer 2010 Sep 28;9:262. Epub 2010 Sep 28.
Department of Pathology, Tumor Immunity Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Jongno-gu, Seoul 110-799, South Korea.

Nuclear factor-kappa B inhibition reduces markedly cell proliferation in Epstein-Barr virus-infected stomach cancer, but affects variably in Epstein-Barr virus-negative stomach cancer.
Cancer Invest 2010 Feb;28(2):113-9
Center for Antimicrobial Resistance and Microbial Genetics, Department of Infectious Diseases, University of Ulsan College of Medicine, Seoul 138-736, Korea.

The multiplex bead array approach to identifying serum biomarkers associated with breast cancer.
Breast Cancer Res 2009 28;11(2):R22. Epub 2009 Apr 28.
Department of Laboratory Medicine and Pathology, The Armed Forces Capital Hospital, Bundnag-Gu, Sungnam City, Gyeonggi-Do, Korea.



Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells.
PLoS One 2013 31;8(12):e84256. Epub 2013 Dec 31.
Tumor Immunity Medical Research Center, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea ; Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea.


MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
BMC Cancer 2016 06 10;16:363. Epub 2016 Jun 10.
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.

OF